Lataa...
Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
Episodic ataxia type 2 (EA2) is an autosomal dominant neurological disorder characterized by paroxysmal attacks of ataxia, vertigo, and nausea that usually last hours to days. It is caused by loss-of-function mutations in CACNA1A, the gene encoding the pore-forming α(1) subunit of P/Q-type voltage-g...
Tallennettuna:
| Julkaisussa: | Biomedicines |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7555146/ https://ncbi.nlm.nih.gov/pubmed/32899500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8090332 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|